by Mike Regan | Jun 30, 2022 | Company Analysis
Canopy Growth (CGC) is issuing between 56.7-78.4 million shares to retire C$255.4 million of its C$600 million convertible note due 2023. The conversion price for this redemption works out to somewhere between US$2.50-3.50, and will be based on the 10 day average...
by Mike and Colin | Feb 14, 2022 | Weekly Extract
Welcome to the Weekly Extract, parsing key information out of the week’s cannabis headlines. This week’s Extract covers …. Recently Published 1Q22 Survey Results published to Premium Members. Extract subscribers will be able to access the results on...
by Mike and Colin | Feb 7, 2022 | Weekly Extract
Welcome to the Weekly Extract, parsing key information out of the week’s cannabis headlines. This week’s Extract covers …. Recently Published: MJResearchCo presentation on SPACs from Fall 2021 Cannabis trades at valuations where consumer companies...
by Mike and Colin | Oct 29, 2021 | Weekly Extract
Welcome to the weekly recap, parsing key information out of cannabis headlines. A quick background: The weekly note has been an internal tool at MJResearchCo, providing our own opinion and analysis on top industry headlines to ensure we’re up to date on cannabis...
by Mike and Colin | Oct 15, 2021 | Company Analysis, M&A / Capital Raise, Macro
Canopy is paying $297.5M for the right to buy Wana Brands when it “Federally permissible”, and Cronos paid $110.4 million for the right to buy 10.5% of Pharmacann when legal. What exactly are they getting, why are they buying, and why is it smart for Wana and...
